Pascal and Francis Bibliographic Databases


Search results

Your search

au.\*:("ROVATI, L. C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 74

  • Page / 3


Selection :

  • and

Clinical research in osteoarthritis : design and results of short-term and long-term trials with disease-modifying drugsROVATI, L. C.International journal of tissue reactions. 1992, Vol 14, Num 5, pp 243-251, issn 0250-0868Article

Perspectives of CCK antagonists in pancreatic research and clinical use. IROVATI, L. C.International journal of pancreatology. 1991, Vol 8, Num 3, pp 215-226, issn 0169-4197, 12 p.Article

Role of circulating choleystokinin in control of fat-induced inhibition of food intake in humansDREWE, J; GADIENT, A; ROVATI, L. C et al.Gastroenterology (New York, NY. 1943). 1992, Vol 102, Num 5, pp 1654-1659, issn 0016-5085Article

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application : A randomized, double-blind, placebo-controlled studyROVATI, L. C; SETNIKAR, I; GENAZZANI, A. R et al.Gynecological endocrinology. 2000, Vol 14, Num 4, pp 282-291, issn 0951-3590Article

Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiolSETNIKAR, I; ROVATI, L. C; VENS-CAPPELL, B et al.Arzneimittel-Forschung. 1996, Vol 46, Num 8, pp 766-773, issn 0004-4172Article

Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis : A double-blind, randomized, parallel-group, placebo-controlled prospective clinical studyMIGLIO, F; ROVATI, L. C; SANTORO, A et al.Arzneimittel-Forschung. 2000, Vol 50, Num 8, pp 722-727, issn 0004-4172Article

Chronic intrathecal cannulation affects hypothalamic beta-endorphin and met-enkephalin concentrationsROVATI, L. C; SACERDOTE, P; BIANCHI, M et al.Journal of pharmacological methods. 1988, Vol 19, Num 1, pp 85-88, issn 0160-5402Article

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis : a pilot studyRINGE, J. D; DORST, A; FABER, H et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 4, pp 296-300, issn 0172-8172, 5 p.Article

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjectsWEBBER, C; ROTH, A; CHASSEAUD, L. F et al.Xenobiotica (London. Print). 2003, Vol 33, Num 6, pp 625-641, issn 0049-8254, 17 p.Article

Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patientsPERSIANI, S; D'AMATO, M; MAKOVEC, F et al.Biopharmaceutics & drug disposition. 2001, Vol 22, Num 2, pp 73-81, issn 0142-2782Article

Treatment of postmenopausal vertebral osteopenia with monofluorophosphate : a long-term calcium-controlled studyGAMBACCIANI, M; SPINETTI, A; TAPONECO, F et al.Osteoporosis international. 1995, Vol 5, Num 6, pp 467-471, issn 0937-941XArticle

Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humansVERHULST, M. L; GIELKENS, H. A. J; HOPMAN, W. P. M et al.Regulatory peptides. 1994, Vol 53, Num 3, pp 185-193, issn 0167-0115Article

Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in manJEBBINK, M. C. W; JANSEN, J. B. M. J; VAN DER KLEIJ, F. G. H et al.European journal of clinical investigation. 1993, Vol 23, Num 9, pp 529-533, issn 0014-2972Article

Effect of a cholecystokinin antagonist, loxiglumide, on pancreatic secretion in patients with chronic pancreatitisADLER, G; REINSHAGEN, M; BEGLINGER, C et al.Biomedical research. 1990, Vol 11, Num 3, pp 151-156, 6 p.Article

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 703-707, issn 0004-4172Article

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsMAKOVEC, F; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 11, pp 1265-1268, issn 0004-4172Article

Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patchSETNIKAR, I; ROVATI, L. C; SANTORO, A et al.Arzneimittel-Forschung. 1999, Vol 49, Num 8, pp 708-715, issn 0004-4172Article

Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphateRINGE, J. D; DORST, A; KIPSHOVEN, C et al.Osteoporosis international. 1998, Vol 8, Num 1, pp 47-52, issn 0937-941XArticle

Effect of cholecystokinin-A receptor blockade on lipid-induced gastric relaxation in humansMESQUITA, M. A; THOMPSON, D. G; TRONCON, L. E. A et al.American journal of physiology. Gastrointestinal and liver physiology. 1997, Vol 36, Num 1, pp G118-G123, issn 0193-1857Article

The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptyingGIELKENS, H. A. J; DE BOER, S. Y; LAM, W. F et al.European journal of gastroenterology & hepatology. 1997, Vol 9, Num 12, pp 1227-1231, issn 0954-691XConference Paper

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growthWATSON, S. A; CROSBEE, D. M; MORRIS, D. L et al.British journal of cancer. 1992, Vol 65, Num 6, pp 879-883, issn 0007-0920Article

Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in manJEBBINK, M. C. W; JANSEN, J. B. M. J; MOOY, D. M et al.Regulatory peptides. 1991, Vol 32, Num 3, pp 361-368, issn 0167-0115, 8 p.Article

Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans : effects of loxiglumideSCHMIDT, W. E; CREUTZFELDT, W; SCHLESER, A et al.American journal of physiology. Gastrointestinal and liver physiology. 1991, Vol 23, Num 2, pp G197-G206, issn 0193-1857Article

Pharmacokinetics of loxiglumide after single intravenous or oral doses in manSETNIKAR, I; CHISTE, R; MAKOVEC, F et al.Arzneimittel-Forschung. 1988, Vol 38, Num 5, pp 716-720, issn 0004-4172Article

Antispasmodic activity on the gallbladder of the mouse of CR 1409 (Lorglumide) a potent antagonist of peripheral CCKMAKOVEC, F; BANI, M; CEREDA, R et al.Pharmacological research communications. 1987, Vol 19, Num 1, pp 41-51, issn 0031-6989Article

  • Page / 3